Delivery Order SPE2DX15D3013-C554
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $77,119.71, is for the delivery of a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. This is a firm-fixed-price delivery order contract with a completion date of November 25, 2016. The contract was not...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,846.93, is for the delivery of a range of pharmaceutical products, medical supplies, and equipment to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. The contract has a firm fixed-price pricing type and an ultimate...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $80,978.00 and is a firm fixed-price delivery order awarded on August 30, 2017, with a completion date of September 18, 2017. The contract is not designated as a set-aside and covers the provision of medical supplies and pharmaceuticals to support TRICARE, the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $112,867.03, is for the provision of a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The award is not designated as a set-aside contract....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $96,927.66, is for the provision of various medical supplies and pharmaceuticals to support TRICARE, the healthcare program for active duty and retired military personnel, under a Firm Fixed Price structure. The contract has no set-aside designation, indicating it was an open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $109,845.57, is for the provision of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract has a firm fixed price pricing structure and runs through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $104,543.53, is a Firm Fixed Price Delivery Order for the provision of medical supplies to support TRICARE, the healthcare program for military personnel, veterans, and their families. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,014.91 contract is for the provision of various medical products and supplies to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract has an ultimate completion date of June 20, 2017 and was not set aside for any specific...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,087.43, is for the supply of various pharmaceutical products and medical supplies to support TRICARE, the Defense Department's healthcare program. The contract is a firm fixed-price delivery order with an ultimate completion date of December 22, 2022. It is not designated as a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $100,445.11, is for the delivery of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract is a firm fixed-price delivery order...
- SPE2DX15D3013Indefinite Delivery Contract
- SPE2DX15D3013-C554Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $96,802.88, is for the delivery of a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 2, 2017. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.8k | 9/29/17 |